Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      TERMINATED
      Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
      Description

      This is an open-label, multicenter, multinational, Phase 2 basket study exploring the efficacy and safety of neratinib as monotherapy or in combination with other therapies in participants with HER (EGFR, HER2) mutation-positive solid tumors.

      Conditions
      Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
      Talk to us